Showing results (91-100 of 125) with videos related to
Sort By:
Pageof 13
Neuroscience|July 21, 2010
Differential effects of nicotine on P50 amplitude, its gating, and their neural sources in low and high suppressorsV J Knott, D J Fisher, A M MillarPerceptual and Motor Skills|August 1, 1978
Effects of tobacco, time on task, and stimulus speed on judgments of velocity and timeJ E Tong, J L Booker, V J KnottNeuropsychobiology|February 15, 2001
Effects of haloperidol pretreatment on the smoking-induced EEG/mood activation response profileD Walker, C Mahoney, V Ilivitsky, et al.Neuropsychobiology|September 10, 1998
The cholinergic basis of the smoking-induced EEG activation profileV J Knott, A Harr, V Ilivitsky, et al.International Clinical Psychopharmacology|March 1, 1995
SSRIs in anxious-agitated depression: a post-hoc analysis of 279 patientsM J Filteau, P Baruch, Y D Lapierre, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1983
Behavioural and biochemical alterations following haloperidol treatment and withdrawal: the animal model of tardive dyskinesia reexaminedS K Rastogi, R B Rastogi, R L Singhal, et al.Journal of Affective Disorders|June 1, 1994
Primary early onset dysthymia, biochemical correlates of the therapeutic response to fluoxetine: II. Urinary metabolites of serotonin, norepinephrine, epinephrine and melatoninA V Ravindran, R J Bialik, G M Brown, et al.Psychiatry Research|October 8, 1999
Norepinephrine transporter gene polymorphism is not associated with susceptibility to major depressionD Owen, L Du, D Bakish, et al.British Journal of Pharmacology|May 1, 1977
Alterations in brain 5-hydroxytryptamine metabolism during the 'withdrawal' phase after chronic treatment with diazepam and bromazepamR A Agarwal, Y D Lapierre, R B Rastogi, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1983
Abnormal involuntary movements in patients on long-acting neurolepticsL K Oyewumi, Y D Lapierre, R Gray, et al.Pageof 13